Retour sur lavenir.net
   CARE PROPERTY INV. 12.420 € (-1,90 %)     SOFINA 221.000 € (-1,16 %)     AEDIFICA 68.050 € (-2,44 %)     KBC ANCORA 76.000 € (-1,55 %)     COFINIMMO 79.900 € (-2,20 %)     AB INBEV 69.560 € (+0,46 %)     MONTEA 65.700 € (-1,20 %)     FAGRON 23.200 € (-0,85 %)     ARGENX SE 692.800 € (-3,51 %)     KBC 112.850 € (-0,70 %)     KINEPOLIS GROUP 30.450 € (+0,50 %)     MELEXIS 85.400 € (+4,98 %)     TUBIZE-FIN 219.400 € (-1,70 %)     NYXOAH 2.505 € (-1,38 %)     COLRUYT 33.060 € (-0,78 %)     WERELDHAVE BELGIUM 52.800 € (-0,38 %)     WDP 21.700 € (-0,82 %)     SHURGARD 23.550 € (-1,05 %)     SOLVAY 26.540 € (+0,30 %)     CMB.TECH 12.720 € (-5,50 %)     CENERGY 24.940 € (-10,29 %)     GBL 82.850 € (+1,10 %)     D'IETEREN GROUP 164.800 € (-2,43 %)     UCB 246.400 € (-3,07 %)     SIPEF 93.300 € (-0,74 %)     AZELIS GROUP 10.320 € (+1,18 %)     ACKERMANS V.HAAREN 262.400 € (-1,20 %)     VGP 78.700 € (-2,48 %)     UMICORE 26.120 € (+3,08 %)     IBA 15.560 € (+0,52 %)     BARCO 9.195 € (+0,60 %)     DEME GROUP 183.400 € (-0,22 %)     BIOTALYS 3.200 € (+5,44 %)     AGEAS 66.100 € (0,00 %)     RETAIL ESTATES 70.300 € (-0,71 %)     DECEUNINCK 2.170 € (+4,58 %)     SYENSQO 68.500 € (+1,26 %)     RECTICEL 10.700 € (-0,74 %)     BEKAERT 42.050 € (+2,19 %)     XIOR 27.050 € (-1,10 %)     TITAN S.A. 49.860 € (-0,08 %)     VIOHALCO 20.800 € (-5,45 %)     ELIA GROUP 132.600 € (+1,22 %)     ONTEX GROUP 2.590 € (-0,19 %)     OPTION 7.340 € (-2,13 %)     PROXIMUS 6.835 € (+1,26 %)     AGFA-GEVAERT 0.446 € (-0,45 %)     EXMAR 11.500 € (-0,43 %)     EVS BROADC.EQUIPM. 31.250 € (+0,32 %)     CFE 13.650 € (-1,80 %)     NEXTENSA 45.820 € (-0,36 %)     SOLVAC NOM(RETAIL) 77.000 € (+0,65 %)     GIMV 46.100 € (-0,97 %)     VASTNED 29.500 € (0,00 %)     EKOPAK 4.365 € (+0,34 %)     ONWARD MEDICAL 2.715 € (-4,40 %)     TINC 11.760 € (-0,34 %)     WAREHOUSES ESTATES 39.900 € (-0,25 %)     HOME INVEST BE. 18.980 € (-0,52 %)     BPOST 1.762 € (+0,69 %)  
   SCHNEIDER ELECTRIC 285.300 € (+3,29 %)     THE NAVIGATOR COMP 3.342 € (-1,01 %)     AIR LIQUIDE 176.840 € (-0,33 %)     TELEPERFORMANCE 62.900 € (-2,21 %)     AIRBUS 172.480 € (-0,40 %)     BENETEAU 6.860 € (0,00 %)     IMCD 89.940 € (-0,27 %)     WOLTERS KLUWER 61.240 € (-4,37 %)     REXEL 37.240 € (+2,59 %)     ABIVAX 66.200 € (-40,79 %)     UNILEVER 47.770 € (-0,22 %)     SARTORIUS STED BIO 175.600 € (-1,07 %)     ASML HOLDING 1 440.200 € (+3,31 %)     MOTA ENGIL 4.534 € (-4,59 %)     PUBLICIS GROUPE SA 84.680 € (-1,40 %)     RIBER 16.300 € (+5,84 %)     GL EVENTS 33.950 € (-2,86 %)     AVANTIUM 9.100 € (+5,20 %)     PROSUS 42.005 € (+7,86 %)     SAINT GOBAIN 76.920 € (+1,00 %)     DSM FIRMENICH AG 70.740 € (-0,92 %)     SEMCO TECHNOLOGIES 55.800 € (+5,68 %)     BIOMERIEUX 70.150 € (-1,89 %)     CREDIT AGRICOLE 16.505 € (+0,33 %)     UMG 18.935 € (-3,07 %)     BE SEMICONDUCTOR 283.300 € (+1,83 %)     RANDSTAD NV 27.230 € (-1,27 %)     EUROCOMMERCIAL 28.150 € (-1,57 %)     ADYEN 895.000 € (-1,84 %)     CAPGEMINI 101.750 € (-6,74 %)     VIRIDIEN 121.900 € (-0,41 %)     EUTELSAT COMMUNIC. 3.540 € (-6,82 %)     AKZO NOBEL 66.180 € (+0,21 %)     WORLDLINE 0.330 € (+1,67 %)     PHARMING GROUP 1.075 € (-4,32 %)     SBM OFFSHORE 33.580 € (-2,44 %)     INVENTIVA 3.620 € (-13,50 %)     GTT 198.100 € (+0,81 %)     SOCIETE GENERALE 69.650 € (-1,65 %)     NEDAP 97.900 € (+1,87 %)     LVMH 473.250 € (+0,73 %)     TOTALENERGIES 76.710 € (+0,43 %)     VALNEVA 2.358 € (-5,94 %)     EIFFAGE 122.800 € (-0,53 %)     HERMES INTL 1 598.000 € (-0,71 %)     KALRAY 13.940 € (-2,24 %)     SIGNIFY NV 21.200 € (+1,83 %)     LOUIS HACHETTE 1.728 € (+0,12 %)     EDP 4.391 € (+1,32 %)     ASM INTERNATIONAL 885.400 € (+2,08 %)     STMICROELECTRONICS 67.180 € (+13,29 %)     GROLLEAU 3.920 € (+4,26 %)     ATOS 40.960 € (+0,89 %)     FLOW TRADERS 24.540 € (-0,97 %)     ING GROEP N.V. 26.645 € (+0,55 %)     X-FAB 11.220 € (+16,33 %)     ARCADIS 36.040 € (+1,92 %)     OSE IMMUNO 3.830 € (-8,33 %)     VIVORYON 1.140 € (-8,06 %)     SOLUTIONS 30 SE 0.747 € (-3,98 %)  
News Réglementées
02/06/2026 13:39

EQS-Adhoc: K+S Aktiengesellschaft: K+S acquires Qemetica's salt business in Poland and Germany (2025 EBITDA: ~EUR 50m); Purchase price between EUR 350m and EUR 380m, depending on performance (Multiple: ~7x)

EQS-Ad-hoc: K+S Aktiengesellschaft / Key word(s): Mergers and Acquisitions / Purchase of parts of a company
K+S Aktiengesellschaft: K+S acquires Qemetica's salt business in Poland and Germany (2025 EBITDA: ~EUR 50m); Purchase price between EUR 350m and EUR 380m, depending on performance (Multiple: ~7x)

02-Jun-2026 / 13:39 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


  • K+S acquires Qemetica's salt business in Poland and Germany (2025 EBITDA: just under EUR 50 million)
  • Purchase price ranging from EUR 350 million to EUR 380 million, depending on performance (Purchase price/EBITDA: ~7x)
  • The acquisition strengthens the Company’s already very stable salt business in Europe sustainably and offers additional growth potential in Central Eastern Europe as well as synergies

On June 2, 2026, the K+S Group, acting through its subsidiary esco international GmbH, signed an agreement to acquire the salt business of Qemetica, located in Janikowo, Poland, and Stassfurt, Germany (2025 revenue: approx. EUR 125 million, 2025 EBITDA: just under EUR 50 million, total assets: just under EUR 200 million, about 400 employees).

The purchase price ranges between EUR 350 million and EUR 380 million, depending on Qemetica Salt’s business success for 2026 and 2027 (Purchase price/EBITDA: ~7x). The closing is subject to the usual closing conditions, including approval by the competition authorities, and is expected in Q1/2027. The K+S Group’s debt ratio (net debt/EBITDA) is expected to remain largely unchanged. K+S is evaluating various financing and capital market instruments to fund the purchase price for the acquisition and to optimize the Group’s financing structure. The timing, implementation, and structure of such financing will depend primarily on developments in the capital market environment and financing conditions. If no financing has been secured by the closing date, K+S can draw on existing liquidity and firmly committed credit lines and, if necessary, refinance at a later date.

For the K+S Group, the acquisition of the two evaporated salt sites in Janikowo, Poland, and Stassfurt, Germany, offers an opportunity to further expand its own very stable salt business in Europe, which is operating in a market environment that has recently seen significant improvements. Moreover, this creates additional growth potential in Central and Eastern Europe as well as synergies. The Qemetica sites focus on the production of salt specialties for water softening and for the food industry.


Contact:
Investor Relations:
Julia Bock, CFA
Phone: +49 561 9301-1009
julia.bock@k-plus-s.com


End of Inside Information

02-Jun-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:K+S Aktiengesellschaft
Bertha-von-Suttner-Str. 7
34131 Kassel
Germany
Phone:+49 561 9301 0
Fax:+49 561 9301 2425
E-mail:investor-relations@k-plus-s.com
Internet:www.k-plus-s.com
ISIN:DE000KSAG888
WKN:KSAG88
Indices:MDAX
Listed:Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
EQS News ID:2338040

 
End of AnnouncementEQS News Service

2338040  02-Jun-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière